Company news

Corvex, Inc. (NASDAQ:MOVE) news

Every Corvex, Inc. press release and news update in one place — announcements, filings coverage, and company updates for investors.

View Corvex, Inc. stock analysis →

Press releases & updates

Corvex Appoints Garrett Brams to Lead Data Center Infrastructure Development

August 28, 2026

Corvex to Host Second Quarter 2026 Earnings Call on Friday, August 14, 2026

August 12, 2026

Corvex Signs Multi-Year Agreement to Provide NVIDIA Blackwell GPUs

August 4, 2026

Corvex Appoints Chance Moreland as CFO to Accelerate Capital Formation, AI Infrastructure Expansion

June 16, 2026

Semiconductor and Computing Veteran Nicholas Donofrio to Join Corvex Board of Directors as the Company Scales Secure AI Infrastructure an...

June 8, 2026

Corvex Reports Q1 2026 Financial Results and Provides Business Update

May 19, 2026

Corvex to Host First Quarter 2026 Earnings Call on Tuesday, May 19, 2026

May 11, 2026

CORVEX, INC. ANNOUNCES ADDITIONAL DETAILS OF SPECIAL 35.8% STOCK DIVIDEND FOR SHAREHOLDERS OF RECORD ON MARCH 30, 2026

March 24, 2026

CORVEX ANNOUNCES CLOSING OF ALL-STOCK MERGER

March 24, 2026

Corvex Launches Secure Model Weights, Delivering Hardware-Enforced Protection for AI Inference on Third-Party Infrastructure

March 12, 2026

Corvex Among the First Companies to Achieve Verified Production Deployment of Confidential Computing for AI on NVIDIA HGX™ B200 Systems

March 3, 2026

Corvex Secures Long-Term NVIDIA H200 GPU Deployment with AI-driven Provider of High-Performance Battery Technologies to Support Productio...

January 22, 2026

MOVE Stock Alert: Halper Sadeh LLC is Investigating Whether the Merger of Movano Inc. is Fair to Shareholders

November 12, 2025

CORVEX TO GO PUBLIC IN ALL-STOCK MERGER WITH MOVANO, CREATING A PURE-PLAY PLATFORM FOR SECURE AI INFRASTRUCTURE AND HIGH-PERFORMANCE INFE...

November 10, 2025

Movano Health Announces Reverse Stock Split

October 8, 2025

Movano Health Granted Listing Extension by Nasdaq

August 28, 2025

Movano Health Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Report on Form 10-Q

August 22, 2025

Movano Health Plans to Timely Request a Hearing Before a Nasdaq Hearings Panel

July 11, 2025

Movano Health's Board of Directors Initiates Process to Maximize Shareholder Value

May 16, 2025

Movano Health's Proprietary Cuffless Blood Pressure Device Once Again Achieves Accuracy Commensurate with the FDA's Requirements

April 22, 2025

Movano's Evie Ring Adds New Personalization and Trend Tracking to Support Women's Wellness Journey

March 10, 2025

Movano Health Commences Clinical Study with New Cuffless Blood Pressure Device

February 4, 2025

Movano Health Launches EvieAI Virtual Wellness Assistant

January 8, 2025

Movano Health Welcomes Dr. Shaheen Wirk to its Board of Directors

January 2, 2025

Movano Health Receives FDA Clearance for EvieMED Ring

December 2, 2024

Movano Health Reports Q3 2024 Financial Results and Provides Business Update

November 14, 2024

Movano Health Announces Completion of Clinical Study with Cuffless RF Blood Pressure Device

November 7, 2024

Movano Health to Report Third Quarter 2024 Financial Results on Thursday November 14, 2024

November 6, 2024

Movano Health Submits Response to FDA as Part of Final Review Phase for EvieMED

November 4, 2024

Movano Health Provides Update on Investigation to Expose Apparent Stock Manipulation Following Reverse Stock Split

November 4, 2024

Movano Health Opens Investigation to Expose Apparent Stock Manipulation Following Reverse Stock Split

October 31, 2024

Evie Ring Announces Brand Partnership with Lifestyle Content Creator Heidi D'Amelio

October 30, 2024

Movano Health Plans Response Submission to FDA Next Week as Part of EvieMED Final Review Phase

October 24, 2024

Movano Health Provides Update on FDA Review of EvieMED Ring

October 10, 2024

Evie, Movano Health's Smart Ring for Women, is Back In Stock with Key Upgrades

September 17, 2024

Movano Health Advances to Final Phase of FDA Review Process for EvieMED Ring

September 3, 2024

Movano Health Reports Q2 2024 Financial Results and Provides Business Update

August 14, 2024

Movano Health to Report Second Quarter 2024 Financial Results on Wednesday August 14, 2024

August 5, 2024

Movano Health Provides Progress Update on EvieMED Regulatory Filing

August 5, 2024

Movano Health Announces Dr. Fatima Rodriguez Joining July 11 Virtual Event

June 28, 2024

Movano Health Applies Advanced AI through Deep Learning to Deliver Improved Accuracy of Heart Rate in Motion

June 13, 2024

MIT Selects Movano Health for Groundbreaking Study on Long COVID and Chronic Lyme Disease

June 10, 2024

Movano Health Reports Q1 2024 Financial Results and Provides Business Update

May 15, 2024

Movano Health Submits Exemplary Sp02 Clinical Trial Results in Key Step Towards FDA 510(k) Clearance Decision

May 9, 2024

Movano Health to Report First Quarter 2024 Financial Results on Wednesday May 15, 2024

May 6, 2024

Movano Health Closes $24 Million Private Placement

April 5, 2024

Movano Health Reports 2023 Financial Results and Provides Business Update

April 4, 2024

Movano Health to Report Fourth Quarter 2023 Financial Results on Thursday, April 4, 2024

April 2, 2024

Movano Health Secures Strategic Investment from Tier-One Multi-Billion Dollar Medical Device Company

April 2, 2024

Movano Health Announces $24 Million Private Placement

April 2, 2024

Older →